The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies von Ichinose, Masakazu, Taniguchi, Hiroyuki, Takizawa, Ayako, Grönke, Lars, Loaiza, Lazaro, Voß, Florian, Zhao, Yihua, Fukuchi, Yoshinosuke

Volltext

Effects of baseline symptom burden on treatment response in COPD von Martinez, Fernando J, Abrahams, Roger A, Ferguson, Gary T, Bjermer, Leif, Grönke, Lars, Voß, Florian, Singh, Dave

Volltext

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO ® and OTEMTO ® studies: a subgroup analysis by age von Ferguson, Gary T, Karpel, Jill P, Clerisme-Beaty, Emmanuelle, Grönke, Lars, Voß, Florian, Buhl, Roland

Volltext

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® s... von Beeh, K M, Derom, E, Echave-Sustaeta, J, Grönke, L, Hamilton, A, Zhai, D, Bjermer, L

Volltext

Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease von Grönke, L, Beeh, K.M, Cameron, R, Kornmann, O, Beier, J, Shaw, M, Holz, O, Buhl, R, Magnussen, H, Jörres, R.A

Volltext

P295 Efficacy and safety of tiotropium/olodaterol in patients with copd by ats category von Maltais, F, Pizzichini, E, Grönke, L, Voß, F, Derom, E

Volltext

P55 Benefits of tiotropium/olodaterol on symptoms and health-related quality of life in patients with moderate to severe COPD with chronic bronchitis and/or emphysema von Ferguson, GT, Abrahams, R, Bjermer, L, Grönke, L, Voß, F, Singh, D

Volltext

P298 Tiotropium/olodaterol therapy provides symptomatic benefits irrespective of prior maintenance treatment: post hoc analyses of the otemto® studies von Abrahams, R, Ferguson, GT, Bjermer, L, Grönke, L, Voß, F, Singh, D

Volltext

P296 Effect of tiotropium/olodaterol therapy on copd exacerbations in the tonado® studies von Derom, E, Fle ar, M, Grönke, L, Voß, F, Buhl, R

Volltext

The diagnosis and management of chronic cough von Morice, A H, Fontana, G A, Sovijarvi, A R A, Pistolesi, M, Chung, K F, Widdicombe, J, O'Connell, F, Geppetti, P, Gronke, L, De Jongste, J, Belvisi, M, Dicpinigaitis, P, Fischer, A, McGarvey, L, Fokkens, W J, Kastelik, J

Volltext

P121 Characteristics of COPD patients with and without maintenance treatment at baseline, by GOLD stage: TONADO von Korn, S, Abrahams, R, Grönke, L, Korducki, L, Amatto, VC, Buhl, R

Volltext

P125 Tiotropium plus olodaterol combination therapy provides lung-function benefits when compared to tiotropium alone, irrespective of prior treatment with a long-acting bronchodil... von Buhl, R, Abrahams, R, Grönke, L, Korducki, L, Fležar, M, Ferguson, GT

Volltext

P121 Characteristics of COPD patients with and without maintenance treatment at baseline, by GOLD stage: TONADO: Abstract P121 Table 1 von Korn, S, Abrahams, R, Grönke, L, Korducki, L, Amatto, VC, Buhl, R

Volltext

P125 Tiotropium plus olodaterol combination therapy provides lung-function benefits when compared to tiotropium alone, irrespective of prior treatment with a long-acting bronchodil... von Buhl, R, Abrahams, R, Grönke, L, Korducki, L, Fležar, M, Ferguson, GT

Volltext

P299 Effects of symptom severity at baseline on lung-function and sgrq responses in the otemto® studies von Martinez, FJ, Abrahams, R, Ferguson, GT, Bjermer, L, Grönke, L, Voß, F, Singh, D

Volltext

P123 Inhaled corticosteroid plus long-acting [beta]2-agonist therapy is overused in the treatment of patients with chronic obstructive pulmonary disease: post hoc analyses of two 1... von Watz, H, Ferguson, GT, Grönke, L, Voß, F, Abrahams, R, Buhl, R

Volltext

P123 Inhaled corticosteroid plus long-acting β2-agonist therapy is overused in the treatment of patients with chronic obstructive pulmonary disease: post hoc analyses of two 1-year... von Watz, H, Ferguson, GT, Grönke, L, Voß, F, Abrahams, R, Buhl, R

Volltext

P123 Inhaled corticosteroid plus long-acting β2-agonist therapy is overused in the treatment of patients with chronic obstructive pulmonary disease: post hoc analyses of two 1-year... von Watz, H, Ferguson, GT, Grönke, L, Voß, F, Abrahams, R, Buhl, R

Volltext

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tio... von Korn, S, Buhl, R, Grönke, L, Korducki, L, Amatto, V C, Ferguson, G T, Abrahams, R

Volltext

S61 Analysis of the efficacy and safety of the combination of tiotropium + olodaterol in patients with COPD by previous usage of inhaled corticosteroids von Korn, S, Buhl, R, Grönke, L, Korducki, L, Amato, VC, Ferguson, GT, Abrahams, R

Volltext